Help us better understand
transfusion-dependent β-thalassemia (TDT)

market research study looking to talk with people  transfusion-dependent β-thalassemia (TDT) and their caregivers.  Your identity and responses will be confidential, but the feedback you give will help shape future care and treatments for sickle cell disease. 

If you qualify and complete a 75 minute interview, you will receive $125 for your time and participation.  

INTERESTED IN PARTICIPATING? WANT MORE INFORMATION?

Submit the form below or contact Michelle at michelle@pinpointpatientrecruiting.com

We are recruiting participants for this market research study on behalf of an independent market research agency acting on behalf of a pharmaceutical company.

By submitting the form above you consent to being contacted by Pinpoint with regards to this study and future studies.